Font Size: a A A
Keyword [KRas]
Result: 21 - 40 | Page: 2 of 10
21. A Study Of Relationship Between RAS-RAF-ERK, PI3K-PTEN-AKT And Colorectal Cancer And Its Liver Metastasis
22. Comparison Of Two Methods Used Ligase Reaction For The Detection Of KRAS, BRAF Gene Mutation
23. The Research Of STK33 Gene And KRAS Gene And EGFR Gene Expression In Lung Cancer
24. MiR-143 Decreases Human Prostate Cancer Cell Proliferation And Migration Through Suppression Of KRAS
25. The Research Of Radiosensitization By RAD001 For The Different PIK3CA Gene And KRAS Gene Type Human NSCLC Cells
26. The Synergistic Role Of Inactivated Smad4 And Activated Kras G12D In Liver Metastasis Of Colon Cancer
27. Exploring Studies On Gene Expression Profile Of Cells With Long-term Low Expression Of Kras And Potential Therapeutic Targets Of Pancreatic Cancer
28. The Study Of Tumor Suppressor Gene RBM5Expression And Its Correlation With EGFR And KRAS In NSCLC
29. Detection Of KRAS Mutation And Advanced Colorectal Cancer Targeting Prognosis Assessment
30. The Role Of RAS Mutation And PHLPP1in Myeloid Leukemia
31. Differential Roles Of Kras And Pten In Murine Postnatal Leukemogenesis And Fetal Hematopoiesis
32. The Expression And Function Of Hsa-miR-30b In Pancreatic Ductal Adenocarcinoma
33. Exploration Of New Therapeutic Targets For The Treatment Of Non-small Cell Lung Cancer
34. MiR-27a Inhibits Tumor Proliferation And Invasion Through Targeting KRAS In Esophageal Squamous Cell Carcinoma
35. The Relationship Between The Abnormality Of Osteogenesis Of Mouse Embryonic Mesenchymal Cells With The Abnormal Gene Expression Of Rb,Kras,P53and Osteosarcomagenesis
36. Clinical Study On Status Of EGFR, EML4-ALK, KRAS Genes In Lung Adenocarcinoma
37. A Novel Molecule, Mir-216B, Is Involved In Pathogenesis And Progression Of Hepatocellular Carcinoma
38. Synergistic Function Of Kras Mutation And HBx In Initiation And Progression Of Hepatocellular Carcinoma In Mice
39. The Screening Study Of Serum MicroRNA Biomarkers With Transgenic KrasG12D Mouse Model Of Pancreatic Pre-malignant Lesions
40. A Novel Drug Combination Suppresses KRAS-mutant Cancers
  <<First  <Prev  Next>  Last>>  Jump to